A breakthrough in snakebite treatment. Researchers from the Technical University of Denmark (DTU) and Liverpool School of Tropical Medicine (LSTM) have co-developed the world’s first product-ready recombinant antivenom that protects against Africa’s most dangerous snakes, including cobras, mambas and rinkhals, and outperforms existing serum-derived products.

By using lab-produced nanobodies instead of animal-derived antibodies, the new therapy offers safer, more consistent protection and can be manufactured at scale, marking a major step forward in global efforts to make antivenoms more effective and accessible.